Melanoma Survival Rate and Vitiligo

Chicago - Among patients receiving a novel immune-based maintenance biotherapy regimen (mBT) for metastatic melanoma, those who developed vitiligo had longer median survival.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.